Clinical Guidelines – Page 3 – Inasl

Clinical Guidelines

Home
Clinical Guidelines

INASL Guidelines

Filter By Year :

Indian National Association for the Study of the Liver-Federation of Obstetric and Gynaecological Societies of India Position Statement on Management of Liver Diseases in Pregnancy

PREGNANCY AFTER LIVER TRANSPLANTATION

Type: Liver Diseases

Year: 2019

Joint Consensus Statement of the Indian NationalAssociation for Study of the Liver and IndianRadiological and Imaging Association for theDiagnosis and Imaging of HepatocellularCarcinoma Incorporating Liver Imaging Reportingand Data System

Journal of Clinical and Experimental Hepatology

Type: Hepatocellular carcinoma (HCC)

Year: 2019

Corrigendum to “Wilson’s Disease: Clinical Practice Guidelines of the Indian National Association for the Study of Liver (INASL), The Indian Society of Pediatric Gastroenterology, Hepatology and Nutrition (ISPGHAN) and the Movement Disorders Society of India (MDSI)” [J Clin Exp Hepatol 9 (2019) 74-98]

J Clin Exp Hepatol 9 (2019) 74-98

Type: Pediatric Gastroenterology

Year: 2019

Indian National Association for the Study of the Liver-Federation of Obstetric and Gynaecological Societies of India Position Statement on Management of Liver Diseases in Pregnancy

Liver Diseases in Pregnancy

Type: HELLP syndrome

Year: 2019

INASL Guidelines on Management of Hepatitis B Virus Infection in Patients receiving Chemotherapy, Biologicals, Immunosupressants, or Corticosteroids

Hepatitis B Virus (HBV)

Type: Virus Infection in Patients

Year: 2018

Corrigendum to “Indian National Association for Study of the Liver (INASL) guidance for antiviral therapy against HCV infection: Update 2016”

HCV Treatment Regimen for Patients with Decompensated Cirrhosis

Type: J. Clin. Exp. Hepatol. 6 (2016)

Year: 2016

INASL Position Statements on Prevention, Diagnosis and Management of Hepatitis B Virus Infection in India: The Andaman Statements

Hepatitis B Virus (HBV)

Type: PHASES OF HBV INFECTION

Year: 2016

Indian National Association for Study of the Liver (INASL) Guidance for Antiviral Therapy Against HCV Infection: Update 2016

Journal of Clinical and Experimental Hepatology

Type: INASL 2G HCV GUIDANCE

Year: 2016

Non-alcoholic Fatty Liver Disease and Metabolic Syndrome-Position Paper of the Indian National Association for the Study of the Liver, Endocrine Society of India, Indian College of Cardiology and Indian Society of Gastroenterology

Non-alcoholic fatty liver disease (NAFLD)

Type: Increasing Obesity, Hypertension, and Diabetes Mellitus

Year: 2015

Indian National Association for Study of the Liver (INASL) Guidance for Antiviral Therapy Against HCV Infection in 2015

Journal of Clinical and Experimental Hepatology

Type: INASL HCV GUIDANCE

Year: 2015

Previous 1 2 3 4 Next

© 2026 Indian National Association for Study of the Liver (INASL). All Rights Reserved.

Developed & Maintained by Oculus Technologies India Pvt. Limited